| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.84B | -19.7% |
| Cost of Revenue | $13.35B | -20.7% |
| R&D Expense | $924.0M | -11.2% |
| SG&A Expense | $1.71B | -8.1% |
| Pre-tax Income | $1.46B | -46.1% |
| Income Tax | $336.0M | -43.4% |
| Net Income | $1.25B | -47.4% |
| EPS (Basic) | $0.99 | -44.4% |
| EPS (Diluted) | $0.99 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.19B | -26.2% |
| Inventory | $4.78B | -13.9% |
| Total Assets | $42.93B | -7.4% |
| Total Liabilities | $35.16B | -7.7% |
| Stockholders' Equity | $7.71B | -5.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.97B | +117.0% |
| Investing Cash Flow | -$2.77B | +25.1% |
| Financing Cash Flow | -$67.0M | -102.6% |
| -43.8% |